By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


IDM, Inc. 

9 Parker

Irvine  California  92618-1605  U.S.A.
Phone: 949-470-4751 Fax: 949-470-6470


Company News
Epimmune Inc. (EPMN) And IDM S.A. Agree To Combine Businesses10/19/2005 5:13:01 PM
Immuno-Designed Molecules Signs An R&D Agreement On Anti-Cancer Vaccine With The Walter Reed Army Institute of Research10/19/2005 5:12:06 PM
The FDA Has Authorized IDM, Inc. To Start A Phase II Trial In The United States On Its Therapeutic Vaccine Uvidem10/19/2005 5:11:36 PM
IDM, Inc. Announces The Opening Of Its cGMP Production Center In The United States10/19/2005 5:10:58 PM
IDM S.A. Will Present Phase II Trial Results For Its Melanoma Cancer Vaccine, Uvidem, At American Society of Clinical Oncology - Orlando - On May 15, 200510/19/2005 5:10:30 PM
IDM, Inc. Announces Detailed Phase III Results For Mepact In Osteosarcoma To Be Presented At ASPHO Annual Meeting10/19/2005 5:10:20 PM
IDM, Inc. Obtains A European Patent Protecting The Basic Technology Behind Its Therapeutic Vaccines10/19/2005 5:09:50 PM
IDM And Cambridge Laboratories Limited Sign An Exclusive Marketing Agreement For Junovan(TM) (Mepact) In The United Kingdom And Ireland10/19/2005 5:09:19 PM
Mepact, IDM, Inc.'s Most Advanced Product, Receives "Orphan Medicinal Product" Designation For The Treatment Of Osteosarcoma In The European Union10/19/2005 5:08:58 PM
IDM, Inc. Announces Appointment Of Guy-Charles Fanneau de la Horie As Vice-President, Director France10/19/2005 5:08:56 PM